PH receives US - COVAX donation of 1.8 million COVID-19 vaccine doses | Inquirer News

PH receives US – COVAX donation of 1.8 million COVID-19 vaccine doses

/ 12:01 PM October 03, 2021

360,000 doses of gov’t-procured Pfizer vaccine arrive in PH

(REUTERS)

MANILA, Philippines — Over 1.8 million doses of Pfizer’s COVID-19 vaccine arrived at the Ninoy Aquino International Airport on Sunday.

The National Task Force Against COVID-19 said  1,813,500 doses donated by the United States government through the COVAX facility of arrived at 3:30a.m.

Article continues after this advertisement

As of October 2, the Philippines has received 75,597,140 COVID-19 vaccine doses.

FEATURED STORIES

A total of  48,719,770 doses were procured by the national government, 17,840,230 doses were donated through the COVAX Facility, 5,398,000 were procured by local government units and private sector while 3,639,140 doses donated by several nations.

Meanwhile, a total of 21,560,795 individuals in the Philippines are now fully vaccinated against COVID-19.

Article continues after this advertisement

RELATED STORIES:

Article continues after this advertisement

PH receives 2.5 million more doses of Sinovac COVID-19 vaccine

Article continues after this advertisement

PH receives over 391,000 Pfizer COVID-19 vaccine doses

PH receives 1.5 million more doses of the Sinovac COVID-19 vaccine

Article continues after this advertisement
 gsg

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Pfizer

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.